Ngā hua rapu - Van de Velde, Ursule

Minimal Functional β-Cell Mass in Intraportal Implants That Reduces Glycemic Variability in Type 1 Diabetic Recipients mā Gillard, Pieter, Hilbrands, Robert, Van de Velde, Ursule, Ling, Zhidong, Lee, Da Hae, Weets, Ilse, Gorus, Frans, De Block, Christophe, Kaufman, Leonard, Mathieu, Chantal, Pipeleers, Daniel, Keymeulen, Bart

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

Preexisting Insulin Autoantibodies Predict Efficacy of Otelixizumab in Preserving Residual β-Cell Function in Recent-Onset Type 1 Diabetes mā Demeester, Simke, Keymeulen, Bart, Kaufman, Leonard, Van Dalem, Annelien, Balti, Eric V., Van de Velde, Ursule, Goubert, Patrick, Verhaeghen, Katrijn, Davidson, Howard W., Wenzlau, Janet M., Weets, Ilse, Pipeleers, Daniel G., Gorus, Frans K.

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa

A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes mā Keymeulen, Bart, van Maurik, André, Inman, Dave, Oliveira, João, McLaughlin, Rene, Gittelman, Rachel M., Roep, Bart O., Gillard, Pieter, Hilbrands, Robert, Gorus, Frans, Mathieu, Chantal, Van de Velde, Ursule, Wisniacki, Nicolas, Napolitano, Antonella

Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa Whiwhi kuputuhi katoa